Role of leukotrienes in killing of Mycobacterium bovis by neutrophils

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 71, Issue 3, 2004, Pages 185-190

  Coffey, Michael Joseph ^a   Phare, Susan M ^a   Peters Golden, Marc ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOTRIENE; LEUKOTRIENE B4;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FATTY ACID SYNTHESIS; HOST RESISTANCE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; NEUTROPHIL; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY, NATURAL; INDOLES; LEUKOTRIENE B4; LEUKOTRIENES; LIPOXYGENASE INHIBITORS; MYCOBACTERIUM BOVIS; NEUTROPHILS;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS;

EID: 3142598660     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2004.03.012     Document Type: Article

References (35)

1. Mancuso P., Nana-Sinkam P., Peters-Golden M. Leukotriene B4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infect Immun. 69:2001;2011-2016
2. Pitrak D.L., Bak P.M., De Marais P., Novak R.M., Andersen B.R. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis. 167:1993;1406-1410
3. Mancuso P., Standiford T.J., Marshall T., Peters-Golden M. 5-lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun. 66:1998;5140-5146
4. HendersonJr W.R. Eicosanoids and lung inflammation. Am Rev Respir Dis. 135:1987;1176-1185
5. 4. J Biol Chem. 264:1989;19469-19472
6. Israel E., Dermarkarian R., Rosenberg M., Sperling R., Taylor G., Rubin P., Drazen J.M. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med. 323:1990;1740-1744
7. 4. Int J Immunopharmac. 11:1989;801-808
8. Bailie M.B., Standiford T.J., Laichalk L.L., Coffey M.J., Strieter R.M., Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol. 157:1996;5221-5224
9. Nelson S., Farkas S., Fotheringham N., Ho H., Marrie T., Movahhed H. Filgrastim in the treatment of hospitalized patients with community acquired pneumonia. Am J Respir Crit Care Med. 153S:1996;A535
10. Denis M., Ghadirian E. Granulocyte-macrophage colony-stimulating factor restricts growth of tubercle bacilli in human macrophages. Immunol Lett. 24:1990;203-206
11. Coffey M.J., George S., Cinti S., Collins J., Brown M., Kazanjian P.H. Neutrophils from patients with AIDS treated with G-CSF demonstrate enhanced killing of Mycobacterium avium. J Infect Dis. 178:1998;1513-1523
12. Bermudez L.E., Martinelli J., Petrofsky M., Kolonoski P., Young L.S. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. J Infect Dis. 169:1994;575-580
13. Bermudez L.E., Petrofsky M., Stevens P. Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice. Immunology. 94:1998;297-303
14. Coffey M.J., Cinti S., Sullivan A., Armstrong W., Kazanjian P.H. Killing of Mycobacterium avium by neutrophils and monocytes from AIDS patients treated with recombinant granulocyte-macrophage colony-stimulating factor. J Infect Dis. 180:1999;229-233
15. Smith P.D., Ohura K., Masur H., Lane H.C., Fauci A.S., Wahl S.M. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest. 74:1984;2121-2128
16. Coffey M.J., Phare S.M., George S., Peters-Golden M., Kazanjian P.H. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J Clin Invest. 102:1998;663-670
17. Coffey M.J., Phare S.M., Cinti S., Peters-Golden M., Kazanjian P.H. Granulocyte-macrophage colonizing-stimulating factor upregulates the defect in 5-lipoxygenase metabolism in neutrophils and monocytes in AIDS. Blood. 94:1999;3897-3905
18. Roilides E., Mertins S., Eddy J., Walsh T.J., Pizzo P.A., Rubin M. Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. J Pediatr. 117:1990;531-540
19. Coffey M., Peters-Golden M., Fantone J.C., Sporn P.H.S. Membrane association of active 5-lipoxygenase in resting cells. evidence for novel regulation of the enzyme in the rat alveolar macrophage J Biol Chem. 267:1992;570-576
20. Coffey M.J., Wilcoxen S.E., Peters-Golden M. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism which accompanies differentiation of peripheral blood monocytes into alveolar macrophages. Am J Respir Cell Mol Biol. 11:1994;153-158
21. Newman G.W., Guarnaccia J.R., Remhold H.G., Kazanjian P.H. Cytokines enhance neutrophils from HIV-negative donors and AIDS patients to inhibit the growth of M. avium in vitro. J Infect Dis. 175:1997;891-900
22. Brennan P.J. Structure of mycobacteria. recent developments in defining cell wall carbohydrates and proteins Rev Infect Dis. 11(Suppl 2):1989;S420-430
23. Brock T.G., McNish R.W., Coffey M.J., Clark Ojo T., Phare S.M., Peters-Golden M. Effect of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes. J Immunol. 156:1996;2522-2527
24. Kolattukudy P.E., Fernandes N.D., Azad A.K., Fitzmaurice A.M., Sirakova T.D. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol Microbiol. 24:1997;263-270
25. Vergne I., Desbat B. Influence of the glycopeptidic moiety of mycobacterial glycopeptidolipids on their lateral organization in phospholipid monolayers. Biochim Biophys Acta. 1467:2000;113-123
26. Coffey M.J., Phare S.M., Peters-Golden M., Huffnagle G.B. Regulation of 5-lipoxygenase metabolism in mononuclear phagocytes by CD4 T lymphocytes. Exp Lung Res. 25:1999;617-630
27. Skerrett S.J., Henderson W.R., Martin T.R. Alveolar macrophage function in rats with severe protein calorie malnutrition. arachidonic acid metabolism, cytokine release, and antimicrobial activity J Immunol. 144:1990;1052-1061
28. Archibald L.K., Kazembe P.N., Nwanyanwu O., Mwansambo C., Reller L.B., Jarvis W.R. Epidemiology of bloodstream infections in a bacille Calmette-Guerin-vaccinated pediatric population in Malawi. J Infect Dis. 188:2003;202-208
29. Mayatepek E., Paul K., Leichsenring M., Pfisterer M., Wagner D., Domann M., Sonntag H.G., Bremer H.J. Influence of dietary (n-3)-polyunsaturated fatty acids on leukotriene B4 and prostaglandin E2 synthesis and course of experimental tuberculosis in guinea pigs. Infection. 22:1994;106-112
30. De Azevedo Canetti C., Hu B., Curtis J.L., Peters-Golden M. Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood. 102:2003;1877-1883
31. Woo C.H., You H.J., Cho S.H., Eom Y.W., Chun J.S., Yoo Y.J., Kim J.H. Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J Biol Chem. 277:2002;8572-8578
32. Herbert M.-J., Takano T., Holthofer H., Brady H.R. Sequential morphologic events during apoptosis of human neutrophils. modulation by lipoxygenase-derived eicosanoids J Immunol. 157:1996;3105-3115
33. Murray J., Ward C., O'Flaherty J.T., Dransfield I., Haslett C., Chilvers E.R., Rossi A.G. Role of leukotrienes in the regulation of human granulocyte behaviour. dissociation between agonist-induced activation and retardation of apoptosis Br J Pharmacol. 139:2003;388-398
34. Moreno S., Miralles P., Diaz M.D., Baraia J., Padilla B., Berenguer J., Alberdi J.C. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis, Survival. Arch Intern Med. 157:1997;1729-1734
35. Coffey M.J., Kaul D., Phare S.M., Kazanjian P.H. Capacity of neutrophils and monocytes from human immunodeficiency virus-infected patients and healthy controls to inhibit growth of Mycobacterium bovis. J Lab Clin Med. 141:2003;330-334